Literature DB >> 1978855

Establishment of a novel immortalized cell line from ataxia telangiectasia fibroblasts and its use for the chromosomal assignment of radiosensitivity gene.

Y Ejima1, M Oshimura, M S Sasaki.   

Abstract

An immortalized cell line was established from a female ataxia telangiectasia (AT) patient by the transfection of primary skin fibroblasts with origin-defective SV40 DNA. The cell line was characterized by a hypodiploid chromosome constitution and radiation hypersensitivity. The established cell line was used as a recipient for microcell-mediated chromosome transfer. Among seven G418-resistant clones obtained by the fusion with microcells from mouse A9 cells carrying a pSV2neo-tagged normal human chromosome 11, three clones showed restoration of radiation resistance with concomitant gain of an extra intact chromosome 11, while the others contained no recognizable or deleted chromosome 11. The association of the presence of 11q14----qter region with the radioresistance suggests the presence of AT gene in this chromosomal region.

Entities:  

Mesh:

Year:  1990        PMID: 1978855     DOI: 10.1080/09553009014552301

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  3 in total

1.  Ataxia-telangiectasia: linkage evidence for genetic heterogeneity.

Authors:  E Sobel; E Lange; N G Jaspers; L Chessa; O Sanal; Y Shiloh; A M Taylor; C M Weemaes; K Lange; R A Gatti
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

2.  Human monochromosome hybrid cell panel characterized by FISH in the JCRB/HSRRB.

Authors:  H Tanabe; Y Nakagawa; D Minegishi; K Hashimoto; N Tanaka; M Oshimura; T Sofuni; H Mizusawa
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

3.  Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts.

Authors:  M S Meyn; J M Lu-Kuo; L B Herzing
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.